Results 211 to 220 of about 25,935 (265)

Tumor-Targeting T₁ MRI Contrast Agents with Antioxidant Effects: Gadolinium Oxide Nanoparticles Grafted with Polydopamine- and Polyserotonin-Conjugated Polyacrylic Acids. [PDF]

ACS Omega
Liu Y, Tegafaw T, Baek A, Ho SL, Zhao D, Chen X, Mulugeta E, Lee H, Nam H, Kim J, Chang Y, Lee GH.   +11 more
europepmc   +1 more source

Guillain-Barré Syndrome as the Initial Manifestation of Lyme Disease: Diagnostic Challenges. [PDF]

Cureus
Elnour A, Sultan N, Monem A, Ghalib K.
europepmc   +1 more source

Data from Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer

Shintaro Kinoshita, Midori Ishii, Jun Ando, Takaharu Kimura, Tomoyuki Yamaguchi, Sakiko Harada, Fumiyuki Takahashi, Kazutaka Nakashima, Yozo Nakazawa, Satoshi Yamazaki, Koichi Ohshima, Kazuhisa Takahashi, Hiromitsu Nakauchi, Miki Ando   +13 more
openalex   +1 more source

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons. [PDF]

Front Oncol
Lode HN, Holko P, Wieczorek A, Śladowska K, Siebert N, Valteau-Couanet D, Garaventa A, Cañete A, Anderson J, Yaniv I, Ash S, Moreno L, Gray J, Luksch R, Laureys G, Owens C, Manzitti C, Troschke-Meurer S, Kawalec P, Ladenstein RL.   +19 more
europepmc   +1 more source

A novel molecular classifier enabling identification and prediction on immunotherapeutic response for MYCN-low pediatric neuroblastoma. [PDF]

Cell Oncol (Dordr)
Yang L, Zhou J, Fu T, Wang J, Zhan X, Shan Y, Gao H, Xie C, Zhang L, Jiang D, Xu M, Zhang M, Gu S.   +12 more
europepmc   +1 more source

Table 2_Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data.xlsx

Arsenij Ustjanzew (19945700), Federico Marini (1710526), Saskia Wagner (22776011), Arthur Wingerter (2823998), Roger Sandhoff (24498), Jörg Faber (2823992), Claudia Paret (133174)   +6 more
openalex   +1 more source

Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins. [PDF]

Discov Oncol
Al-Khreisat MJ, Abdulsahib WK, Jasim IK, Malathi H, Nayak PP, Anand DA, Mukherjee G, Sinha A, Ruziyeva G.   +8 more
europepmc   +1 more source

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer. [PDF]

NPJ Breast Cancer
Anand V, Oderinde B, Siddiqui M, Tyagi A, Borgman J, Wu C, Andreeff M, Battula VL.   +7 more
europepmc   +1 more source

Role of Anti-GD₂ Targeted PEG-<i>b</i>-PLGA Nanoparticles in the Treatment of MYCN Driven Neuroblastoma. [PDF]

ACS Appl Bio Mater
Gokbayrak O, Ozel D, Tuncel A, Yurt F, Kolatan HE, Erol A, Serinan EO, Aktas T, Yilmaz O, Aktas S.   +9 more
europepmc   +1 more source

Editorial: Decoding tumor plasticity: integrative analysis of epigenetic regulation and microenvironmental adaptation. [PDF]

Front Immunol
Wang R, Wang H, Zhou JG, Yang GJ.
europepmc   +1 more source